科技报告详细信息
| Gas Chromatographic/Mass Spectrometric Differentiation of Atenolol, Metoprolol, Propranolol, and an Interfering Metabolite Product of Metoprolol | |
| Angier MK, Lewis RJ, Chaturvedi AK, and Canfield DV | |
| FAA Office of Aerospace Medicine - Civil Aerospace Medical Institute | |
| 关键词: Forensic Science; Toxicology; Gas Chromatography/ Mass Spectrometery; Atenolol; Metoprolol; Propranolol; Interfering Metoprolol Metabolite Product; | |
| RP-ID : DOT/FAA/AM-04/15 | |
| 美国|英语 | |
| 来源: Federal Aviation Administration | |
PDF
|
|
【 摘 要 】
Pilots who successfully control their hypertension with medications, diet, and/or exercise can be medically certified to fly an aircraft. At the present time, approximately 8% of active pilots are designated as "hypertensive with medication" by the Federal Aviation Administration (FAA). One of the groups of antihypertensives is the beta-blocker. Of this group, atenolol, metoprolol, and propranolol are commonly prescribed, and they also have chemical and structural similarities.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| Full Text | 191KB |
PDF